2-(4-Phenylpiperidino)cyclohexanol (AH-5183) is a noncompetitive and potent inhibitor of high-affinity acetylcholine transport into cholinergic vesicles. It is reported here that [3H]AH5183 binds specifically and saturably to slide-mounted sections of the rat forebrain (Kd = 1.1 to 2.2 x 10-8 M; Bm.. = 286 to 399 fmol/mg of protein). The association and dissociation rate constants for [3HJAH5183 binding are 8.6
[31H]AH5183 can be displaced by nonradioactive AH5183 and by the structural analog (2a,3,f,4A,8,8Aa)-decahydro-3-(4-phenyl-l-piperidinyl)-2-naphthalenol but not by 10 ,uM concentrations of the cholinergic drugs acetylcholine, choline, atropine, hexamethonium, eserine, or hemicholinium-3 or by the structurally related compounds 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenylpyridine, (±)-N-allylnormetazocine (SKF 10,047), levoxadrol, or dexoxadrol. reduced by 33 ± 6% and 61 + 7%, respectively. These findings indicate that [3H]AH5183 binds to a unique recognition site in rat brain that is topographically associated with cholinergic nerve terminals.
Brittain and coworkers (1, 2) reported that 2-(4-phenylpiperidino)cyclohexanol (AH5183), a structural isomer of hydroxylated phencyclidine, inhibits the coaxially stimulated contractions of the isolated guinea pig ileum. Because AH5183 did not affect the contractions elicited by the addition of acetylcholine (AcCho) to the bath, it was proposed that AH5183 produces a "selective prejunctional inhibition" of cholinergic neurotransmission (1, 2) . Based on the pharmacological characteristics of the neuromuscular blockade produced by AH5183 in vivo (1, 2) , in vitro, and in situ (3) (4) (5) , Marshall hypothesized that AH5183 inhibits the loading of AcCho into synaptic vesicles. In support of Marshall's hypothesis, synaptic vesicles isolated from the electric organ of Torpedo californica, a model system for the mammalian cholinergic synapse (6) , have been shown to acquire AcCho by an active transport process that is pharmacologically distinct from other cholinergic systems (7) . AH5183 is the most potent inhibitor of this transport system, half inhibiting AcCho uptake at 40 nM in a noncompetitive manner (7, 8) . AH5183 also has been found to inhibit the uptake of newly synthesized AcCho into synaptic storage vesicles in PC12 cells (9, 10) and, presumably as a secondary effect, to inhibit the release of AcCho from the cat superior cervical ganglion in situ (11) and from rat and mouse brain preparations in vitro (12) (13) (14) . Remarkably, the above studies could not demonstrate significant direct effects of AH5183 on high-affinity choline uptake, choline acetyltransferase (ChoAcTase) activity, Ca2l influx, or the vesicular content of previously loaded AcCho.
Tritium-labeled AH5183 binds to a site in Torpedo vesicles that is saturable, of high affinity (Kd = 3.4 x 10-8 M), selective for the 1-enantiomer of the drug, and not occupied by AcCho or choline (15) . The [3H]AH5183 (15) (17) .
Kd and Bmax Calculations. Values for Bmax and Kd were calculated from swabbing and autoradiographic binding data according to the best fit to a parabola by iterative, nonlinear regression analysis (20) .
Transsection of the Septohippocampal Pathway. To produce a unilateral destruction of the septohippocampal cholinergic terminals, the left fimbria was transsected (21) . The intact right hemisphere served as the control. Seven days after the surgery, the rats were decapitated and the brains were removed. Coronal sections of brain were cut at the level of the hippocampus, -3.2 mm anterior to the interaural plane (16) . The sections were processed through the [3H]AH5183 binding assay as described above, and regional binding (see Fig. 3 Lower) was measured by quantitative autoradiography. Samples of the left and right hippocampus were dissected from the remaining brain tissue and were assayed for ChoAcTase activity (22 (Fig. 1 Upper) , the specific binding of [3H]AH5183 increased rapidly during the first 4 min of incubation and reached equilibrium by 30 min. The association rate constant (k+1) was 8.6 x 106 M-1min-1 when calculated from a pseudo-first-order plot of the time course ( Fig. 1 Upper Inset) . Specific binding to brain sections also showed a rapid dissociation rate (kL1) of 1.8 x 10-1 min-' (Fig. 1 Lower) . The pseudo-first-order and first-order plots of the time course of association or dissociation of [3H]AH5183 were linear, which suggests that this is a bimolecular reaction obeying simple mass-action kinetics. The equilibrium dissociation constant, or Kd, calculated from the kinetic rate constants (kL1/k+1) was 2.1 x 10-8 M.
Saturation analysis of the specific binding of [3H]AH5183 determined under optimal conditions (Fig. 2) Binding of [3H]AH5183 in the left hippocampus 7 days after transsection of the ipsilateral fimbria was studied. Hippocampal ChoAcTase activity was reduced by 61 ± 7% in the right hemisphere. *P < 0.01, n = five rats.
of AcCho transport by at least a factor of 250 than is AH5183 (7). Thus, it seems unlikely that the [3H]AH5183 binding site in brain corresponds to either a muscarinic or nicotinic receptor, the enzymes ChoAcTase or AcCho esterase, or the high-affinity choline transport system.
The pharmacological specificity ofthe [3H]AH5183 binding site in brain is demonstrated also by the lack of displacement by structurally related drugs. The binding of [3H]AH5183, a structural isomer of hydroxylated phencyclidine, was not affected by dexoxadrol or levoxadrol, which are enantiomers that exhibit stereoselectivity (IC50 = 21 and 6100 nM, respectively) for a high-affinity phencyclidine receptor in brain (25) . Furthermore, the possibility that [3H]AH5183 recognizes phencyclidine receptors (25) (Fig. 3) resembled the cortical distribution of ChoAcTase activity (30) and immunoreactivity (31) . Similarly, the distinct medial-to-lateral increase of
[3H]AH5183 binding sites observed in the autoradiographic images of the caudate-putamen corresponded with similar gradients of ChoAcTase activity (32) and high-affinity choline uptake (33) measured in microdissected areas of the caudate-putamen. We recently determined (34) that concentrations of [3H]AH5183 binding in 14-18 brain areas correlated highly (r = 0.88 -0.97) and significantly (P < 0.01) with regional levels of ChoAcTase (35, 36) , AcCho esterase (16, 37) , and AcCho itself (35, 36) . The [3H]AH5183 binding site in the forebrain was also strikingly similar to the autoradiographic distribution (38, 39) and pH optimum and binding affinity (38, 40) 
